Who has invested in PhaseV?

Accel, Insight Partners, Viola Ventures, EXOR, LionBird are named among the investors backing PhaseV.

PhaseV Funding: $65M Raised, Series A (2025)

PhaseV funding overview

PhaseV is a Healthtech company based in Boston, MA. PhaseV has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2025. The round record for PhaseV runs through 2025; nothing later has been disclosed. Investors on record include Accel, Insight Partners, Viola Ventures, EXOR, LionBird. 5 distinct backers are named across the disclosed rounds.

PhaseV at a glance

Total raised: $65M
Latest round: Series A
Latest round date: May 2025
Industry: Healthtech
Headquarters: Boston, MA
Notable investors: Accel, Insight Partners, Viola Ventures, EXOR, LionBird

Frequently asked about PhaseV funding

How much has PhaseV raised?: PhaseV has raised $65M in total disclosed funding across the rounds on record.
Who has invested in PhaseV?: Accel, Insight Partners, Viola Ventures, EXOR, LionBird are named among the investors backing PhaseV.
What was the latest PhaseV funding round?: The most recent disclosed round is a Series A, announced in May 2025.
Where is PhaseV based?: PhaseV is based in Boston, MA.
What sector does PhaseV operate in?: PhaseV is tracked under Healthtech from Boston, MA, with $65M in disclosed funding.
When did PhaseV last raise?: The last disclosed PhaseV round closed in May 2025 at Series A.

Totals shown for PhaseV aggregate every disclosed round on file. To see how that compares, browse the Healthtech companies in Boston and the investors behind them below.

PhaseV Funding: $65M Raised, Series A (2025)

PhaseV funding overview

PhaseV at a glance

Frequently asked about PhaseV funding

PhaseV founders (1)

Companies related to PhaseV (40)

Browse related funding lists (8)